SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-18-015593
Filing Date
2018-03-07
Accepted
2018-03-07 17:30:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 a18-7765_1424b5.htm 424B5 609278
2 GRAPHIC g77651bg05i001.jpg GRAPHIC 39532
3 GRAPHIC g77651bg13i001.jpg GRAPHIC 3635
4 GRAPHIC g77651hoi001.jpg GRAPHIC 5850
5 GRAPHIC g77651bg01i001.jpg GRAPHIC 3238
  Complete submission text file 0001104659-18-015593.txt   682801
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217102 | Film No.: 18674258
SIC: 2834 Pharmaceutical Preparations